Rentschler Biopharma has appointed Dr. Ralf Otto as chief operating officer, effective February 1, 2018. He will be responsible for development, manufacturing and quality management.    “We are very pleased to welcome Dr. Otto to the management team of Rentschler Biopharma SE. In our industry, Dr. Otto has an excellent reputation as a thought leader and proven his expertise in strategy and corporate management. He combines extensive experience in biopharmaceutical manufacturing, outstand...